Twenty-seven people failed to reach a consensus Although the European Commission has called for countermeasures to be “as coordinated as possible”, they did agree that more research on its impact is necessary.
The EU Health Minister met through a video conference this Wednesday to analyze the conclusion of the European Medicines Agency (EMA), which confirmed AstraZeneca’s “possible link” to thrombosis cases, Although he maintains a positive view on the benefits of vaccines.
At the meeting, “EU member states shared Different interpretations of conclusions” Reports of European institutions, as stated in the report of the EU President Portugal.
Impossible to achieve the “coordinated” response requested by both Portugal and the Committee, which recommended 27 Risk of “confusing” citizens If it does not reach “one voice”.
“It is vital that we take a coordinated position in Europe. This position should not make citizens peaceful do not doubt European Vaccine Commissioner Stella Kyriakides asks questions about vaccines because it is based on science.
The Portuguese Minister of Health Marta Temido has the same position, he emphasized the decision to use AstraZeneca It is “technical” rather than “political.” He warned: “We must continue to follow the best scientific information published by EMA. We must never forget that personal decisions affect everyone.”
The EU countries have indeed reached a consensus on the need for action More research on the impact of vaccines In a specific group.
The EMA Safety Committee (PRAC) was unable to determine the risk factors for abnormal thrombosis cases reported after vaccination, such as age, gender or past medical history, although it explained: A “reasonable explanation” is that they are an immune response to vaccines. Therefore, they requested new research to try to gather more information.
Emer Cooke, the executive director of EMA, tried to clarify doubts at the meeting of ministers of health. She assured the minister of health that all targets against covid-19 and They will update their recommendations “when necessary.”
In the absence of a coordinated position within the EU, more countries will make a decision on Wednesday Unilateral restrictions on the use of AstraZeneca vaccines.
among them Spain, Health authorities recommend that local governments only inject AstraZeneca’s covid-19 vaccine to people over 60. So far, in Spain, these doses have only been applied to people under 65 years of age.
A similar decision is made by Italy, From now on, it will recommend AstraZeneca for “priority use” From the age of 60.
Belgium It further restricts the use of this vaccine and can only vaccinate people Over 55 The next four weeks
More and more European countries are restricting AstraZeneca, for example Germany, It has stopped taking these doses for people under 60.
Netherlands Considering that AstraZeneca’s vaccination on Wednesday is “The Dilemma of All Member States” The European Union, because this formulation puts them between “health risks due to very rare side effects” and “delayed vaccination”.